Mutational and Structural Analysis of Conserved Residues in Ribose-5-Phosphate Isomerase B from Leishmania donovani: Role in Substrate Recognition and Conformational Stability.
Ribose-5-phosphate isomerase B from Leishmania donovani (LdRpiB) is one of the potential drug targets against visceral leishmaniasis. In the present study, we have targeted several conserved amino acids for mutational analysis (i.e. Cys69, His11, His102, His138, Asp45, Tyr46, Pro47 and Glu149) to ga...
Main Authors: | Preet Kamal Kaur, Neha Tripathi, Jayesh Desale, Soumya Neelagiri, Shailendra Yadav, Prasad V Bharatam, Sushma Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4783025?pdf=render |
Similar Items
-
Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.
by: Pramod K Kushawaha, et al.
Published: (2012-01-01) -
Structural and Functional Studies of Ribose-5-phosphate isomerase B
by: Roos, Annette K.
Published: (2007) -
Functional characterization of Leishmania infantum asparagine synthetase A and ribose 5-phosphate Isomerase B as potential drug targets
by: Joana Raquel Correia Faria
Published: (2019) -
The Study of Ribose-5-phosphate Isomerase A in the Formation of Liver Cancer
by: Ciou, Shih Ci, et al.
Published: (2015) -
Overexpression of Ribose-5-phosphate Isomerase A facilitates oncogenicity in the human cells
by: Liu, Yu-Lin, et al.
Published: (2012)